LivaNova has published 12-month data supporting its proximal hypoglossal nerve stimulation (pHGNS) system for sleep apnea.

Nihon Kohden, a global leader in neurodiagnostic, patient, monitoring and ventilation, today announced it is expanding the ...

ProSomnus Sleep Technologies ("the Company"), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy® and pioneer in Smart Sleep Medicine, today ...

RMD's growth strategy, rising device demand and solid finances support momentum, but macro pressures and stiff competition could test its outlook.

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that the journal Annals of Internal ...

SnoreRX examines its FDA-cleared mandibular advancement mouthpiece design, 1-millimeter adjustable calibration, boil-and-bite ...

RPMO₂ features a fully embedded oximeter over maxillary dentition, using buccal vestibule mucosa behind the upper lip.

The latest type 2 diabetes (T2D) management guidance from the American Association of Clinical Endocrinology (AACE) covers ...

Could you provide an overview of the Develop hypersomnia Understanding by Evaluating low-sodium oxybate Treatment (DUET) ...

Weight-loss drugs, finding use in wellness and weddings alike, promise a booster shot for India’s generics giants. It needs to be administered with care though ...

Even though India prohibits direct-to-consumer marketing of prescription drugs, regulators are watching out for messaging to ...

Xywav is a prescription oxybate oral solution taken at night for narcolepsy and idiopathic hypersomnia. Patient pay can be low on some commercial plans with ...